- Bright Green (OTC:BGXXQ) announced merger with PharmAGRI Capital Partners, a federally aligned pharmaceutical infrastructure platform architected to restore U.S. drug manufacturing sovereignty.
- Effective immediately, Lynn Stockwell has been appointed CEO and Chairwoman of PharmAGRI.
- The transaction consolidates BGXX’s DEA registrations, Board of Pharmacy licensure, audited financials, and Nasdaq history into PharmAGRI under a court-supervised restructuring plan filed in the District of New Mexico.
- The company intends to complete its IPO before year-end 2025, positioning PharmAGRI for full market access.